Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gator Bio is a life science technology company that specializes in high-performance biolayer interferometry (BLI) systems for biomolecular analysis. The company provides a range of instruments and biosensors designed to measure kinetics, affinity, and concentration of various molecules, including antibodies, proteins, and viral vectors like AAV. Their technology is utilized in drug discovery, development, and manufacturing to streamline workflows and provide real-time, label-free data. Headquartered in Palo Alto, Gator Bio aims to offer more sensitive and cost-effective alternatives to traditional analytical methods. The platform is particularly valued for its ability to handle crude samples and provide high-throughput analysis for researchers in both academia and industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gator Bio.